These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31107222)

  • 1. Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018.
    Ilori EA; Furuse Y; Ipadeola OB; Dan-Nwafor CC; Abubakar A; Womi-Eteng OE; Ogbaini-Emovon E; Okogbenin S; Unigwe U; Ogah E; Ayodeji O; Abejegah C; Liasu AA; Musa EO; Woldetsadik SF; Lasuba CLP; Alemu W; Ihekweazu C;
    Emerg Infect Dis; 2019 Jun; 25(6):1066-1074. PubMed ID: 31107222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in Lassa Fever Cases in Nigeria, January-March 2018.
    Ilori EA; Frank C; Dan-Nwafor CC; Ipadeola O; Krings A; Ukponu W; Womi-Eteng OE; Adeyemo A; Mutbam SK; Musa EO; Lasuba CLP; Alemu W; Okogbenin S; Ogbaini E; Unigwe U; Ogah E; Onoh R; Abejegah C; Ayodeji O; Ihekweazu C
    Emerg Infect Dis; 2019 May; 25(5):1026-1027. PubMed ID: 30807268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).
    Ajayi NA; Nwigwe CG; Azuogu BN; Onyire BN; Nwonwu EU; Ogbonnaya LU; Onwe FI; Ekaete T; Günther S; Ukwaja KN
    Int J Infect Dis; 2013 Nov; 17(11):e1011-6. PubMed ID: 23871405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study.
    Duvignaud A; Jaspard M; Etafo IC; Gabillard D; Serra B; Abejegah C; le Gal C; Abidoye AT; Doutchi M; Owhin S; Séri B; Vihundira JK; Bérerd-Camara M; Schaeffer J; Danet N; Augier A; Ogbaini-Emovon E; Salam AP; Ahmed LA; Duraffour S; Horby P; Günther S; Adedosu AN; Ayodeji OO; Anglaret X; Malvy D;
    Lancet Glob Health; 2021 Apr; 9(4):e469-e478. PubMed ID: 33740408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria.
    Salu OB; Amoo OS; Shaibu JO; Abejegah C; Ayodeji O; Musa AZ; Idigbe I; Ezechi OC; Audu RA; Salako BL; Omilabu SA
    Pan Afr Med J; 2020; 36():253. PubMed ID: 33014249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
    Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection pattern, case fatality rate and spread of Lassa virus in Nigeria.
    Yaro CA; Kogi E; Opara KN; Batiha GE; Baty RS; Albrakati A; Altalbawy FMA; Etuh IU; Oni JP
    BMC Infect Dis; 2021 Feb; 21(1):149. PubMed ID: 33546623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and outcome of Lassa fever among hospitalized patients in Ebonyi State, Nigeria, 2018-2019.
    Nwafor IE; Ogah OE; Ojide CK; Odeh EC; Abu AM; Chika-Igwenyi NM; Nwidi DU; Unigwe US; Ajayi NA; Eke MAS; Obasi MN; Adeke AS; Onyia V; Duruiheoma R; Igboke NC; Otti J; Ogbu O
    Virus Res; 2020 Aug; 285():198000. PubMed ID: 32380207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Lassa Fever and Factors Associated with Deaths, Bauchi State, Nigeria, 2015-2018.
    Abdulkarim MA; Babale SM; Umeokonkwo CD; Bamgboye EA; Bashorun AT; Usman AA; Balogun MS
    Emerg Infect Dis; 2020 Apr; 26(4):799-801. PubMed ID: 32186504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early onset of neurological features differentiates two outbreaks of Lassa fever in Ebonyi state, Nigeria during 2017-2018.
    Chika-Igwenyi NM; Harrison RE; Psarra C; Gil-Cuesta J; Gulamhusein M; Onwe EO; Onoh RC; Unigwe US; Ajayi NA; Nnadozie UU; Ojide CK; Nwidi DU; Ezeanosike O; Sampson E; Adeke AS; Ugwu CN; Anebonam U; Tshiang JK; Maikere J; Reid A
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009169. PubMed ID: 33684118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing "One Health" community surveillance and emergency response practice.
    Tambo E; Adetunde OT; Olalubi OA
    Infect Dis Poverty; 2018 Apr; 7(1):37. PubMed ID: 29703243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective Cohort Study of Lassa Fever in Pregnancy, Southern Nigeria.
    Okogbenin S; Okoeguale J; Akpede G; Colubri A; Barnes KG; Mehta S; Eifediyi R; Okogbo F; Eigbefoh J; Momoh M; Rafiu M; Adomeh D; Odia I; Aire C; Atafo R; Okonofua M; Pahlman M; Becker-Ziaja B; Asogun D; Okokhere P; Happi C; Günther S; Sabeti PC; Ogbaini-Emovon E
    Emerg Infect Dis; 2019 Aug; 25(8):1494-500. PubMed ID: 31310586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological trends of Lassa fever in Nigeria, 2018-2021.
    Dalhat MM; Olayinka A; Meremikwu MM; Dan-Nwafor C; Iniobong A; Ntoimo LF; Onoh I; Mba S; Ohonsi C; Arinze C; Esu EB; Nwafor O; Oladipupo I; Onoja M; Ilori E; Okonofua F; Ochu CL; Igumbor EU; Adetifa I
    PLoS One; 2022; 17(12):e0279467. PubMed ID: 36584167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lassa Fever in Travelers from West Africa, 1969-2016.
    Kofman A; Choi MJ; Rollin PE
    Emerg Infect Dis; 2019 Feb; 25(2):245-248. PubMed ID: 30666924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descriptive epidemiology of Lassa fever in Nigeria, 2012-2017.
    Okoro OA; Bamgboye E; Dan-Nwafor C; Umeokonkwo C; Ilori E; Yashe R; Balogun M; Nguku P; Ihekweazu C
    Pan Afr Med J; 2020; 37():15. PubMed ID: 33062117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria.
    Happi AN; Olumade TJ; Ogunsanya OA; Sijuwola AE; Ogunleye SC; Oguzie JU; Nwofoke C; Ugwu CA; Okoro SJ; Otuh PI; Ngele LN; Ojo OO; Adelabu A; Adeleye RF; Oyejide NE; Njaka CS; Heeney JL; Happi CT
    Microbiol Spectr; 2022 Aug; 10(4):e0036622. PubMed ID: 35913205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lassa fever in post-conflict sierra leone.
    Shaffer JG; Grant DS; Schieffelin JS; Boisen ML; Goba A; Hartnett JN; Levy DC; Yenni RE; Moses LM; Fullah M; Momoh M; Fonnie M; Fonnie R; Kanneh L; Koroma VJ; Kargbo K; Ottomassathien D; Muncy IJ; Jones AB; Illick MM; Kulakosky PC; Haislip AM; Bishop CM; Elliot DH; Brown BL; Zhu H; Hastie KM; Andersen KG; Gire SK; Tabrizi S; Tariyal R; Stremlau M; Matschiner A; Sampey DB; Spence JS; Cross RW; Geisbert JB; Folarin OA; Happi CT; Pitts KR; Geske FJ; Geisbert TW; Saphire EO; Robinson JE; Wilson RB; Sabeti PC; Henderson LA; Khan SH; Bausch DG; Branco LM; Garry RF;
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2748. PubMed ID: 24651047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the COVID-19 pandemic masking the deadlier Lassa fever epidemic in Nigeria?
    Reuben RC; Danladi MMA; Pennap GR
    J Clin Virol; 2020 Jul; 128():104434. PubMed ID: 32434707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lassa virus RNA detection from suspected cases in Nigeria, 2011-2017.
    Babalola SO; Babatunde JA; Remilekun OM; Amaobichukwu AR; Abiodun AM; Jide I; Adeshina AI; Chikwe I; Aremu OS
    Pan Afr Med J; 2019; 34():76. PubMed ID: 31819792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phylogeography of Lassa Virus in Nigeria.
    Ehichioya DU; Dellicour S; Pahlmann M; Rieger T; Oestereich L; Becker-Ziaja B; Cadar D; Ighodalo Y; Olokor T; Omomoh E; Oyakhilome J; Omiunu R; Agbukor J; Ebo B; Aiyepada J; Ebhodaghe P; Osiemi B; Ehikhametalor S; Akhilomen P; Airende M; Esumeh R; Muoebonam E; Giwa R; Ekanem A; Igenegbale G; Odigie G; Okonofua G; Enigbe R; Omonegho Yerumoh E; Pallasch E; Bockholt S; Kafetzopoulou LE; Duraffour S; Okokhere PO; Akpede GO; Okogbenin SA; Odia I; Aire C; Akpede N; Tobin E; Ogbaini-Emovon E; Lemey P; Adomeh DI; Asogun DA; Günther S
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.